W. Andrew Robinson
Chemical compound
Pharmaceutical compound
![]() | |
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C35H55NO3 |
Molar mass | 537.829 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Nabazenil (SP-175) is a synthetic cannabinoid receptor agonist, which has anticonvulsant properties.[1]
References
Receptor (ligands) |
| ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (modulators) |
| ||||||||||||||||||||||||||||||
Enzyme (modulators) |
| ||||||||||||||||||||||||||||||
Others |
| ||||||||||||||||||||||||||||||
|
Credit: Wikipedia https://en.wikipedia.org/wiki/Nabazenil